Does phone messaging improves tuberculosis treatment success? A systematic review and meta-analysis.

Tytuł:: Does phone messaging improves tuberculosis treatment success? A systematic review and meta-analysis.
Autorzy:: Gashu KD; Department of Health Informatics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. .
Gelaye KA; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Mekonnen ZA; Department of Health Informatics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Lester R; Research Pavilion, Rm 566, 828 W 10th, University of British Columbia, Vancouver, BC, V5Z 1 M9, Canada.
Tilahun B; Department of Health Informatics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.; Research Pavilion, Rm 566, 828 W 10th, University of British Columbia, Vancouver, BC, V5Z 1 M9, Canada.
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Jan 14; Vol. 20 (1), pp. 42. Date of Electronic Publication: 2020 Jan 14.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
Język:: English
Imprint Name(s):: Original Publication: London : BioMed Central, [2001-
MeSH Terms:: Cell Phone*
Text Messaging*
Telemedicine/*methods
Tuberculosis/*therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Appointments and Schedules ; Female ; Humans ; Male ; Middle Aged ; Non-Randomized Controlled Trials as Topic ; Patient Compliance ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Tuberculosis/diagnosis ; Young Adult
References:: J Clin Tuberc Other Mycobact Dis. 2019 Jun 06;16:100108. (PMID: 31720432)
J Int AIDS Soc. 2014 Aug 01;17:19032. (PMID: 25095831)
J Pediatr Hematol Oncol. 2009 Aug;31(8):571-6. (PMID: 19636266)
Southeast Asian J Trop Med Public Health. 2011 Nov;42(6):1444-51. (PMID: 22299414)
PLoS One. 2013 May 28;8(5):e64662. (PMID: 23724075)
MMWR Recomm Rep. 2005 Dec 30;54(RR-17):1-141. (PMID: 16382216)
Matern Child Health J. 2014 Dec;18(10):2261-74. (PMID: 24043557)
Int J Tuberc Lung Dis. 2013 Jun;17(6):719-27. (PMID: 23541232)
BMC Infect Dis. 2013 Dec 02;13:566. (PMID: 24295439)
JMIR Mhealth Uhealth. 2016 May 13;4(2):e25. (PMID: 27177591)
Qual Saf Health Care. 2006 Jun;15(3):191-5. (PMID: 16751469)
J Nurs Scholarsh. 2003;35(3):207. (PMID: 14562485)
PLoS Med. 2015 Sep 15;12(9):e1001876. (PMID: 26372470)
Fam Pract. 2005 Dec;22(6):638-43. (PMID: 16055472)
Control Clin Trials. 1986 Sep;7(3):177-88. (PMID: 3802833)
Wkly Epidemiol Rec. 2004 Jan 9;79(1-2):6-11. (PMID: 14746111)
Patient Prefer Adherence. 2017 Aug 31;11:1479-1487. (PMID: 28919720)
Eur Respir J. 2018 Feb 7;51(2):. (PMID: 29437940)
Int J Tuberc Lung Dis. 2015 Sep;19(9):1057-64. (PMID: 26260824)
Neuroimmunomodulation. 2002-2003;10(5):270-82. (PMID: 12759564)
Glob Health Action. 2016 Jun 27;9:31543. (PMID: 27357074)
PLoS One. 2018 Sep 21;13(9):e0204091. (PMID: 30240417)
Health Serv Res. 2012 Apr;47(2):614-32. (PMID: 22091980)
Clin Infect Dis. 2001 Dec 15;33(12):2082-4. (PMID: 11698993)
BMC Public Health. 2018 May 2;18(1):583. (PMID: 29720146)
PLoS One. 2014 Mar 27;9(3):e92754. (PMID: 24675985)
Ann Intern Med. 2017 Nov 21;167(10):689-697. (PMID: 29114781)
Med Sci Monit. 2017 May 23;23:2465-2469. (PMID: 28534476)
J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):154-60. (PMID: 27632145)
MMWR Morb Mortal Wkly Rep. 2017 Apr 14;66(14):387-389. (PMID: 28406884)
J Public Health Manag Pract. 2017 Mar/Apr;23(2):175-177. (PMID: 27598709)
PLoS One. 2016 Nov 1;11(11):e0162944. (PMID: 27802283)
Annu Rev Public Health. 2015 Mar 18;36:393-415. (PMID: 25785892)
Lancet. 2009 Jan 3;373(9657):15-6. (PMID: 19125443)
PLoS One. 2013 Nov 11;8(11):e78791. (PMID: 24244364)
Eur Respir J. 2015 Dec;46(6):1563-76. (PMID: 26405286)
BMJ. 2011 Feb 10;342:d549. (PMID: 21310794)
BMC Fam Pract. 2005 Nov 07;6:47. (PMID: 16274481)
Eur Respir J. 2018 Jan 11;51(1):. (PMID: 29326332)
Am J Prev Med. 2010 Jul;39(1):78-80. (PMID: 20537846)
Eur Respir J. 2016 Jul;48(1):29-45. (PMID: 27230443)
J Clin Epidemiol. 2011 Apr;64(4):383-94. (PMID: 21195583)
Jpn J Nurs Sci. 2017 Apr;14(2):112-116. (PMID: 27412502)
Int J Clin Pract. 2015 Jan;69(1):9-32. (PMID: 25472682)
Cochrane Database Syst Rev. 2014 Nov 18;(11):CD006594. (PMID: 25403701)
Tuberc Res Treat. 2013;2013:349394. (PMID: 24455238)
Lancet. 2010 Nov 27;376(9755):1838-45. (PMID: 21071074)
Contributed Indexing:: Keywords: Mobile phone; Text messaging; Treatment success; Tuberculosis
Entry Date(s):: Date Created: 20200116 Date Completed: 20200406 Latest Revision: 20240327
Update Code:: 20240327
PubMed Central ID:: PMC6961375
DOI:: 10.1186/s12879-020-4765-x
PMID:: 31937260
: Czasopismo naukowe

Pełny tekst

Background: Compliance to anti-TB treatment is crucial in achieving cure and avoiding the emergence of drug resistance. Electronic health (eHealth) interventions are included in the strategy to end the global Tuberculosis (TB) epidemic by 2035. Evidences showed that mobile messaging systems could improve patient adherence to clinic appointment for diagnosis and treatment. This review aimed to assess the effect of mobile-phone messaging on anti-TB treatment success.
Methods: All randomized controlled trial (RCT) and quasi-experimental studies done prior to August 26, 2019 were included in the review. Studies were retrieved from PubMed, EMBASE, Cochrane and ScienceDirect databases including, grey and non-indexed literatures from Google and Google scholar. Quality of studies were independently assessed using Cochrane Risk of Bias Assessment Tool. A qualitative synthesis and quantitative pooled estimation were used to measure the effect of phone messaging on TB treatment success rate. PRISMA flow diagrams were used to summarize article selection process.
Results: A total of 1237 articles were identified, with 14 meeting the eligibility criteria for qualitative synthesis. Eight studies with a total of 5680 TB patients (2733 in intervention and 2947 in control groups) were included in meta-analysis. The pooled effect of mobile-phone messaging revealed a small increase in treatment success compared to standard of care (RR 1.04, 95% CI 1.02 to 1.06), with low heterogeneity (I 2 = 7%, p < 0.0002). In the review, performance, detection and attrition biases were reported as major risk of biases.
Conclusions: Mobile-phone messaging showed a modest effect in improving anti-TB treatment success; however, the quality of evidence was low. Further controlled studies are needed to increase the evidence-base on the role of mHealth interventions to improve TB care.
Protocol Registration Number: CRD420170744339. http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017074439.

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja